ALBERT

Notes: After almost 100 years of sporadic, and marginally successful, studies of neural transplantation in animals, we are now on the threshold of a clinical treatment of the damaged brain. The initial studies of neural transplantation have focused on Parkinson's disease, primarily as a model for a more general strategy of “repair by cellular replacement.” Parkinson's is known to result from the loss of a small population of cells that produce the essential neuromodulator, dopamine, for much of the brain. Further, the disease is improved significantly, during the early part of its course, by chemical augmentation of dopamine activity through drug therapies, such as l-dopa. Finally, the disease is often fatal in spite of the best medical treatments, therefore justifying more radical therapeutic experiments. If transplantation of brain cells can be accomplished successfully in humans, as it has been in animals, then replacement of a small population of dopamine-producing cells in Parkinson's disease should have important functional effects and possibly reverse the course and symptoms of the disease. Other useful applications will surely follow for conditions affecting millions of people for whom medicine now has only palliative and ineffective treatments.Just as Parkinson's disease is a model clinical condition for testing cellular replacements, fetal neural tissue transplants are also a first step for a broader strategy of molecular and cellular therapies. Fetal cells are, in many respects, the best replacements one could imagine, since precursor cells have the capacity to develop into every cell found in the adult. So, the best replacement for a dopamine neuron would likely be a precursor dopamine neuron or “neuroblast.” Animal research through 1985 had demonstrated the unique properties of such fetal cells, but survivability after transplantation had not been attained with primate or human neural tissue. Our programs developed techniques to transplant monkey fetal neural tissue, to cryopreserve it, and to reverse functional effects of the neurotoxin, MPTP, in monkeys. This technique was applied to the collection and preservation of human tissue, and preliminary successful results have been obtained in patients with idiopathic Parkinson's disease. Others have reported success with different techniques in two MPTP-Parkinsonian patients and a small number of patients with idiopathic disease. If the most dramatic improvements can be replicated consistently and the benefits last for a reasonable period without complications, a clinical treatment might develop using “random-source” fetal cadaver cells.

Notes: Erwinia Stewartii contains a large cluster of wts genes that are required by this bacterium for pathogenicity on com plants. Three complementation groups within the right half of this cluster, wtsA, wtsC, and ivtsB, were previously identified. In this study, WtsA was found to be a positive activator of ivfsB::lacZ expression. The WtsA locus was sequenced and a single open reading frame is present within the wtsA locus, which has the capacity to encode a 323 amino acid polypeptide. A corresponding 38kDa protein was observed in Escherichia coli minicells containing the cloned wtsA gene. The predicted WtsA polypeptide has significant similarity to HrpS from Pseudomonas syringae pv. phaseolicola, as well as other members of the NtrC class of prokaryotic regulatory proteins. Similar to other genes activated by NtrC regulators, wtsB::lacZ expression in E. coli was dependent upon rpoN.

Notes: Amyloid β-protein, or β/A4, is a 4-kilodalton peptide that forms poorly soluble extracellular depositions of amyloid in brains and leptomeninges of patients with Alzheimer's disease (AD), Down's syndrome (DS), and hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). β/A4 peptide is a derivative of a large transmembrane glycoprotein (APP) and is found in the extracellular space, i.e., in the cerebrospinal fluid and serum of individuals with and without AD and in the conditioned media of many different cells grown in culture.1 The mechanism by which normally produced amyloid β peptide forms extracellular aggregates in patients is unknown. One possible explanation is a failure of a mechanism for removal of the β/A4 peptide that prevents this highly aggregating peptide from forming extracellular amyloid depositions.

Notes: Typical pork sausage patties (40% fat), low-fat (8%) control patties, and low-fat (8%) patties with 20% added water and 0.4% carrageenan were compared to identical treatments containing 2% potassium lactate. The lactate had no effect on percent discoloration or lean color during refrigerated aerobic storage. Sensory properties of pork sausage treatments were not affected by the lactate salt (P〈0.05). Bacterial populations of low-fat pork sausage patties did not differ (P〉0.05); however, the typical patties with 2% potassium lactate had lower (P〈0.05) microbial numbers during refrigerated storage than typical fresh pork sausage. TBARS,‘L’,‘a’and‘b’values were unaffected by the potassium lactate (P〉0.05).

Notes: Abstract Archaean greenstone belts are often cut by major shear zones, for example the Cadillac tectonic zone (CTZ) of the southern Abitibi region in north-western Quebec. At McWatters, the CTZ contains slices of metavolcanic units bounded by corridors of highly strained and altered rocks. Mineral assemblages of the metabasites record the metamorphic evolution of the CTZ.The McWatters metabasalts and metagabbros have similar chemistry but different mineral assemblages consisting of variable amounts of actinolite, hornblende, chlorite, albite, epidote, quartz, carbonates, titanite, biotite, rutile, magnetite, ilmenite and sulphides. The different mineral assemblages, which coexist in a single tectonic slice, can be divided into three types, characterized by (A) presence of hornblende and actinolite, (B) presence of actinolite and epidote, and (C) absence of amphibole and epidote. Partial replacements indicate that these mineral assemblages are not in equilibrium. The hornblende of the least altered and deformed samples of the type A assemblage is a relict of a prograde metamorphic event, contemporaneous with the development of the main schistosity. The prograde conditions are estimated at P= 5 kbar, T= 475° C with low Pf. The more altered and deformed samples of the type C assemblage record a later retrograde metamorphic event. Conditions of the later event are estimated at P= 4 kbar, T= 400° C with higher Pf. Widespread calcite precipitation occurred during a later episode. The diversity of the mineral assemblages results from permeability variations along the high-strain zones of the CTZ.

Notes: Abstract An outcrop of staurolite-bearing pelitic schist from the Solitude Range in the south-western Rocky Mountains, British Columbia, was examined in order to determine the nature of prograde garnet- and staurolite-producing reactions using information from garnet zoning and inclusion mineralogy. Although not present as a matrix phase, chloritoid is present as inclusions in garnet and is interpreted to have participated in the simultaneous growth of garnet and staurolite by a reaction such as chloritoid + quartz = garnet + staurolite + H2O.A garnet zoning trend reversal, which is most pronounced with respect to almandine and grossular components, is present in the outer core of garnets. The location of the zoning reversal corresponds to the outer limit of chloritoid inclusions in garnet. As there is no evidence for polymetamorphism, the zoning reversal is interpreted to indicate continued garnet growth by prograde reaction(s) during a single metamorphic event after the exhaustion of chloritoid as a matrix phase.Metamorphic conditions recorded by mineral rim compositions are 550–600° C at 6–7 kbar. Because there is no evidence for partial resorption of garnet during production of staurolite, we interpret these results to represent peak conditions.